OralCDx aids in monitoring leukoplakia
The OralCDx (Oral Cancer Prevention International) brush test demonstrated high sensitivity and specificity values in diagnosing and monitoring oral leukoplakia, according to a study in
The OralCDx (Oral Cancer Prevention International) brush test demonstrated high sensitivity and specificity values in diagnosing and monitoring oral leukoplakia, according to a study in
The U.S. Food and Drug Administration has approved a national clinical trial to study the safety and effectiveness of a drug treatment on patients receiving
Improving and maintaining health factors not traditionally associated with dementia, such as denture fit, vision, and hearing, may lower a person’s risk for developing dementia,
With the alarming rise in the rate of oropharyngeal cancer among men being linked to the human papillomavirus (HPV), the U.S. Centers for Disease Control
Dental implants provide an important alternative in the oral rehabilitation of oral cancer patients, according to a study in the Australian Dental Journal (June 2011,
Imaging technology provider Verisante Technology has entered into an exclusive agreement to license the worldwide rights for a novel multispectral imaging cancer detection technology with
A new study published in the American Journal of Transplantation reveals an association between certain types of human papillomavirus (HPV) infection and cutaneous squamous cell
Obstructive sleep apnea may cause changes in blood vessel function that reduce blood supply to the heart in people who are otherwise healthy, according to
Researchers at the University of Helsinki in Finland have described a new, recessively inherited human syndrome featuring craniosynostosis, maxillary hyperplasia, delayed tooth eruption, and extra
LONDON (Reuters) – More than a billion people in 19 countries are now covered by laws requiring large, graphic health warnings on tobacco packs, but
Oral Cancer Prevention International (OCPI), makers of the Oral CDx brush test for oral cancer detection, is suing Johnson & Johnson (J&J) for at least
A team of researchers at King’s College London and the Forsyth Institute have been awarded a follow-on grant by the U.S. National Institute for Dental